A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
Artios Pharma Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Beijing Biotech
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
Eli Lilly and Company
BicycleTx Limited
M.D. Anderson Cancer Center
Centre Leon Berard
Coherus Oncology, Inc.
ViroMissile, Inc.
I-Mab Biopharma US Limited
Astellas Pharma Inc
Cedars-Sinai Medical Center
Boston Scientific Corporation
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
ALX Oncology Inc.
Eli Lilly and Company
Angiex, Inc.
NiKang Therapeutics, Inc.
Pfizer
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pfizer
General Oncology, Inc.
DualityBio Inc.
Kyowa Kirin Co., Ltd.
Zhejiang University
Eli Lilly and Company
AstraZeneca
IDEAYA Biosciences
MOMA Therapeutics
The Methodist Hospital Research Institute
Plexium, Inc.
Massachusetts General Hospital
M.D. Anderson Cancer Center